WebApr 13, 2024 · Nearly 5.92% of Curis Inc.’s shares belong to company insiders and institutional investors own 39.60% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.35 million shares as on Mar 14, 2024, resulting in a short ratio of 5.41. Web1 day ago · Click here to access A+ stock grades COMPANY SUMMARY Curis, Inc. is a biotechnology company. The Company is focused on the development of therapeutics for the treatment of cancer. Its clinical stage drug candidates are Emavusertib and CI-8993.
Curis Reports Inducement Grants Under NASDAQ Listing Rule …
WebGet the latest Curis, Inc. (CRIS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebMar 30, 2024 · CRIS.A - Curis, Inc. Stock Price & Latest News Reuters reuters.com - September 18 at 10:38 AM: Curis To Present At H.C. Wainwright Global Investment … songs that i can hear
Curis Inc. (CRIS) Shares Up Despite Recent Market Volatility
WebApr 12, 2024 · Curis Inc. (NASDAQ: CRIS)’s stock price has increased by 17.49 compared to its previous closing price of 0.65. Despite this, the company has seen a gain of 33.75% in its stock price over the last five trading days. ... Based on Curis Inc. (CRIS), the company’s capital structure generated 114.76 points at debt to equity in total, while total ... WebCRIS Complete Curis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Web21 hours ago · Curis (CRIS) (Real Time Quote from BATS) $0.92 USD +0.09 (10.44%) Updated Apr 13, 2024 01:57 PM ET Add to portfolio Zacks Rank: 2-Buy 2 Style Scores: C Value D Growth F Momentum D VGM... small game hunting license minnesota